Ivan Dimov, Rick Klausner (File photos)
#ASH20: Orca’s team showcases their first cut of the data on promising cell purification work for HSCT
For decades now hematopoietic stem-cell transplantation has offered a risky, possibly life-threatening and sometimes curative effort for treating hematological malignancies.
Taking some lessons from Irv …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.